Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Norbert Stefan

Showing results (51-60 of 302) with videos related to

Pageof 31
Sort By:
Nature Reviews. Endocrinology|January 22, 2021
Global pandemics interconnected - obesity, impaired metabolic health and COVID-19Norbert Stefan, Andreas L Birkenfeld, Matthias B Schulze
Trials|June 10, 2024
Effect of essential phospholipids on hepatic steatosis in metabolic dysfunction-associated steatotic liver disease associated with type 2 diabetes mellitus and/or hyperlipidemia and/or obesity: study protocol of a randomized, double-blind, phase IV clinical trialNorbert Stefan, Marek Hartleb, Branko Popovic, et al.
The Lancet. Diabetes & Endocrinology|September 19, 2017
Metabolically healthy obesity: the low-hanging fruit in obesity treatment?Norbert Stefan, Hans-Ulrich Häring, Matthias B Schulze
JAMA|November 10, 2025
Metabolic Dysfunction-Associated Steatotic Liver Disease in Adults: A ReviewHerbert Tilg, Salvatore Petta, Norbert Stefan, et al.
Annals of Internal Medicine|March 3, 2020
Lipodystrophic Nonalcoholic Fatty Liver Disease Induced by Immune Checkpoint BlockadeThomas Eigentler, Diana Lomberg, Jürgen Machann, et al.
American Journal of Physiology. Endocrinology and Metabolism|February 13, 2003
Elevated plasma nonesterified fatty acids are associated with deterioration of acute insulin response in IGT but not NGTNorbert Stefan, Michael Stumvoll, Clifton Bogardus, et al.
The Lancet. Diabetes & Endocrinology|December 16, 2024
Metabolic dysfunction-associated steatotic liver disease: heterogeneous pathomechanisms and effectiveness of metabolism-based treatmentNorbert Stefan, Hannele Yki-Järvinen, Brent A Neuschwander-Tetri
Digestive Diseases (Basel, Switzerland)|May 13, 2010
Environmental and genetic determinants of fatty liver in humansKonstantinos Kantartzis, Fritz Schick, Hans-Ulrich Häring, et al.
The Lancet. Diabetes & Endocrinology|May 18, 2016
Phenotypes of prediabetes and stratification of cardiometabolic riskNorbert Stefan, Andreas Fritsche, Fritz Schick, et al.
Diabetes Care|May 27, 2004
Adiponectin in youth: response to Bacha et alNorbert Stefan, Michael Stumvoll, Hans-Ulrich Häring, et al.
Pageof 31

Showing results (51-60 of 302) with videos related to

Sort By:
Pageof 31
Nature Reviews. Endocrinology|January 22, 2021
Global pandemics interconnected - obesity, impaired metabolic health and COVID-19Norbert Stefan, Andreas L Birkenfeld, Matthias B Schulze
Trials|June 10, 2024
Effect of essential phospholipids on hepatic steatosis in metabolic dysfunction-associated steatotic liver disease associated with type 2 diabetes mellitus and/or hyperlipidemia and/or obesity: study protocol of a randomized, double-blind, phase IV clinical trialNorbert Stefan, Marek Hartleb, Branko Popovic, et al.
The Lancet. Diabetes & Endocrinology|September 19, 2017
Metabolically healthy obesity: the low-hanging fruit in obesity treatment?Norbert Stefan, Hans-Ulrich Häring, Matthias B Schulze
JAMA|November 10, 2025
Metabolic Dysfunction-Associated Steatotic Liver Disease in Adults: A ReviewHerbert Tilg, Salvatore Petta, Norbert Stefan, et al.
Annals of Internal Medicine|March 3, 2020
Lipodystrophic Nonalcoholic Fatty Liver Disease Induced by Immune Checkpoint BlockadeThomas Eigentler, Diana Lomberg, Jürgen Machann, et al.
American Journal of Physiology. Endocrinology and Metabolism|February 13, 2003
Elevated plasma nonesterified fatty acids are associated with deterioration of acute insulin response in IGT but not NGTNorbert Stefan, Michael Stumvoll, Clifton Bogardus, et al.
The Lancet. Diabetes & Endocrinology|December 16, 2024
Metabolic dysfunction-associated steatotic liver disease: heterogeneous pathomechanisms and effectiveness of metabolism-based treatmentNorbert Stefan, Hannele Yki-Järvinen, Brent A Neuschwander-Tetri
Digestive Diseases (Basel, Switzerland)|May 13, 2010
Environmental and genetic determinants of fatty liver in humansKonstantinos Kantartzis, Fritz Schick, Hans-Ulrich Häring, et al.
The Lancet. Diabetes & Endocrinology|May 18, 2016
Phenotypes of prediabetes and stratification of cardiometabolic riskNorbert Stefan, Andreas Fritsche, Fritz Schick, et al.
Diabetes Care|May 27, 2004
Adiponectin in youth: response to Bacha et alNorbert Stefan, Michael Stumvoll, Hans-Ulrich Häring, et al.
Pageof 31